In September 2022, President Joe Biden signed an executive order directing federal agencies to coordinate work on biotechnology and biomanufacturing. The order identified applications involving health, agriculture, energy, supply chains, and national security, and called for attention to safety and ethical concerns. It also discussed advances in genetic engineering and biological data. Critics raised questions about the potential uses and oversight of emerging technologies, but the order itself did not establish the more sweeping claims suggested by some commentary about human genetic modification.
